Biotech startup exits stealth mode with $47M funding boost

02/14/2013 | Xconomy

Jounce Therapeutics has emerged from its quiet period with $47 million in initial funding. The biotech startup from Third Rock Ventures seeks to develop injectable protein drugs including antibodies as therapies for cancer.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ